Lake Street Maintains Sight Sciences(SGHT.US) With Hold Rating, Maintains Target Price $5

Futu NewsDec 21 03:31 · Ratings

Lake Street Issues a Hold Rating on Sight Sciences (SGHT)

TipRanksDec 21 02:39 · Ratings

Sight Sciences Announces the Results of a Budget Impact Analysis for Its TearCare System for the Treatment of Meibomian Gland Disease ("MGD") Showing Cost Savings Over Existing Reimbursed Treatment Options

GlobeNewswireDec 20 05:05

Sight Sciences Is Maintained at Neutral by Citigroup

Dow JonesDec 12 03:32 · Ratings

Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Cuts Target Price to $4.6

Futu NewsDec 11 20:31 · Ratings

Express News | Sight Sciences Inc : Citigroup Cuts Target Price to $4.6 From $5.8

BreakingsDec 11 20:22